Suppr超能文献

纳曲酮用于酒精依赖治疗。

Naltrexone in alcohol dependence.

作者信息

Hartmann P M

机构信息

York Hospital, Pennsylvania, USA.

出版信息

Am Fam Physician. 1997 Apr;55(5):1877-9, 1883-4.

PMID:9105212
Abstract

Naltrexone is a narcotic antagonist that has been shown to reduce alcohol craving and alcohol use in patients with alcohol dependence. It should not be used as exclusive treatment but only as an adjunct to a comprehensive program that includes psychologic and social treatment approaches such as those in Alcoholics Anonymous or professional programs. The two most serious complications of naltrexone therapy are the precipitation of narcotic withdrawal in patients taking narcotics, and hepatotoxicity. The latter complication occurs only at dosages much higher than the 50 mg per day recommended for treatment of alcohol dependence. Alcohol is known to enhance opioid receptors. Evidently, naltrexone blockade of these receptors results in reduced craving for alcohol, less of a "high" while drinking and less alcohol use.

摘要

纳曲酮是一种麻醉拮抗剂,已被证明可减少酒精依赖患者对酒精的渴望和饮酒量。它不应作为唯一的治疗方法,而只能作为综合治疗方案的辅助手段,该方案应包括心理和社会治疗方法,如匿名戒酒会或专业项目中的方法。纳曲酮治疗最严重的两种并发症是正在服用麻醉药品的患者出现麻醉药品戒断反应,以及肝毒性。后一种并发症仅在剂量远高于推荐用于治疗酒精依赖的每日50毫克时才会发生。已知酒精会增强阿片受体。显然,纳曲酮对这些受体的阻断导致对酒精的渴望减少、饮酒时的“兴奋感”降低以及饮酒量减少。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验